Liquidia (LQDA) Intangibles (2020 - 2026)
Liquidia's (LQDA) quarterly Intangibles came in at $2.9 million in Q1 2026, down 48.63% year-on-year from $5.6 million in Q1 2025, and down 48.63% quarter-over-quarter from $5.6 million in Q4 2025.
Liquidia (LQDA) Intangibles (2020 - 2026) Analysis & Trends
Liquidia's Intangibles history runs 7 years deep, the most recent figure standing at $2.9 million for Q1 2026.
- On a quarterly basis, Intangibles fell 48.63% year-over-year to $2.9 million in Q1 2026; TTM through Mar 2026 was $2.9 million, a 48.63% decrease from a year earlier, with the FY2025 full-year figure at $5.6 million, up 78.07% from the prior year.
- Intangibles eased to $2.9 million in Q1 2026 per LQDA's latest filing, from $5.6 million in the prior quarter.
- Across five years, Intangibles topped out at $5.6 million in Q4 2022 and bottomed at $2.9 million in Q1 2026.
- The 5-year median for Intangibles is $4.2 million (2022), against an average of $4.5 million.
- Across the five-year window, Intangibles surged 78.07% in 2025 and sank 48.63% in 2026, its largest moves.
- Year by year, Intangibles stood at $5.6 million in 2022, then plunged by 38.97% to $3.4 million in 2023, then slipped by 7.99% to $3.2 million in 2024, then surged by 78.07% to $5.6 million in 2025, then sank by 48.63% to $2.9 million in 2026.
- Per Business Quant, the three latest LQDA Intangibles figures stand at $2.9 million (Q1 2026), $5.6 million (Q4 2025), and $3.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn | 2.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.89 Mn |
| Dec 31, 2025 | 5.62 Mn |
| Sep 30, 2025 | 2.99 Mn |
| Jun 30, 2025 | 5.62 Mn |
| Mar 31, 2025 | 5.62 Mn |
| Dec 31, 2024 | 3.16 Mn |
| Sep 30, 2024 | 3.22 Mn |
| Jun 30, 2024 | 5.62 Mn |
| Mar 31, 2024 | 5.62 Mn |
| Dec 31, 2023 | 3.43 Mn |
| Sep 30, 2023 | 5.62 Mn |
| Jun 30, 2023 | 3.55 Mn |
| Mar 31, 2023 | 5.62 Mn |
| Dec 31, 2022 | 5.62 Mn |
| Sep 30, 2022 | 3.81 Mn |
| Jun 30, 2022 | 4.04 Mn |
| Mar 31, 2022 | 4.23 Mn |
| Dec 31, 2021 | 4.39 Mn |
| Sep 30, 2021 | 4.52 Mn |
| Jun 30, 2021 | 4.85 Mn |